Spain's Almirall in talks with 'dozens' of firms to license China assets, CEO says
By Andrew Silver SHANGHAI, March 12 (Reuters) - Almirall is in talks with "dozens" of companies from China to license rights to medicines for other markets, CEO Carlos Gallardo said on Thursday, as the Spanish pharmaceutical company competes with rivals...
Reuters